Literature DB >> 8587474

Characterization of big endothelin-1-induced contraction in rabbit saphenous artery.

P Ferlenga1, G Morazzoni, B Da Ros, E Branca, M Fantoni, F Marchini, F Pocchiari, C Semeraro.   

Abstract

We have characterized the endothelin-converting enzyme (ECE)-like activity involved in big endothelin (ET)-1-induced contraction in rabbit saphenous artery (RSA). Big ET-1 30 nM caused a contraction that was independent of the vascular endothelium. Phosphoramidon and the neutral endopeptidase (NEP) inhibitors thiorphan and candoxatrilat blocked the vasoconstriction caused by big ET-1 in endothelium-denuded RSA. Candoxatrilat (IC50 17 nM) and thiorphan (IC50 2.5 nM), were 5- to 30-fold more potent than phosphoramidon (IC50 83 nM). Other protease inhibitors were inactive. In cultured endothelial cells the ET-1 release was inhibited only by phosphoramidon (IC50 16 microM) but at a concentration 200-fold that required an endothelium-denuded RSA. In conclusion, we can speculate that the big ET-1 contraction in RSA is mediated by an ECE, probably present on smooth muscle cells, which is susceptible to NEP inhibitors and is different from the ECE on endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587474

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

1.  Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.

Authors:  J Petersson; G C Hanson; B F Lindberg; E D Högestätt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Role of endothelium in vasomotor responses to endothelin system and protein kinase C activation in porcine retinal arterioles.

Authors:  Luke B Potts; Patrick D Bradley; Wenjuan Xu; Lih Kuo; Travis W Hein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-15       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.